APO Research
Talk to an analyst

APO RESEARCH · REPORT

10% Dextrose Injection

10% Dextrose Injection is a packaged medical solution or multi-compartment preparation supplied for an identified parenteral-use specification.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Composition, compartment arrangement, container integrity and labelled use distinguish the product. Mixing compatibility, clinical selection and administration are separate product-specific requirements.

The commercial boundary

The selected edition describes a market scope. Product approvals, labelled use and clinical acceptance require their own evidence; neither report segmentation nor an illustrative image establishes medical suitability.

Which composition and container configuration define the preparation?

Composition, compartment arrangement, container integrity and labelled use distinguish the product. Mixing compatibility, clinical selection and administration are separate product-specific requirements.

Selected research

Market Structure

Global 10% Dextrose Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

2 January 2026189 pages

Choose your research edition.

Industry Research10% Dextrose Injection Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal 10% Dextrose Injection Industry Growth and Trends Forecast to 203290 pages · $3,450 USDMarket StructureGlobal 10% Dextrose Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032189 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal 10% Dextrose Injection Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal 10% Dextrose Injection Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global 10% Dextrose Injection market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for 10% Dextrose Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for 10% Dextrose Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for 10% Dextrose Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for 10% Dextrose Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of 10% Dextrose Injection include Pfizer, Fresenius Kabi, Baxter, Schwitz Biotech, Otsuka Pharmaceutical, ICU Medical, Drugfield Pharmaceuticals Limited, B. Braun Medical Inc and Alfa Laboratories, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global 10% Dextrose Injection market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of 10% Dextrose Injection and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents 10% Dextrose Injection sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the 10% Dextrose Injection market size, projected growth trends, production technologies, key applications, and end-use industries.

10% Dextrose Injection Segment by Company

Pfizer

Fresenius Kabi

Baxter

Schwitz Biotech

Otsuka Pharmaceutical

ICU Medical

Drugfield Pharmaceuticals Limited

B. Braun Medical Inc

Alfa Laboratories

10% Dextrose Injection Segment by Type

1000 mL

250 mL

500 mL

10% Dextrose Injection Segment by Application

Trophotherapy

Sports

First-Aid Treatment

Others

10% Dextrose Injection Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global 10% Dextrose Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of 10% Dextrose Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of 10% Dextrose Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the 10% Dextrose Injection market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of 10% Dextrose Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of 10% Dextrose Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of 10% Dextrose Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. 10% Dextrose Injection Industry Trends Table 2. 10% Dextrose Injection Industry Drivers Table 3. 10% Dextrose Injection Industry Opportunities and Challenges Table 4. 10% Dextrose Injection Industry Restraints Table 5. Global 10% Dextrose Injection Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global 10% Dextrose Injection Revenue Market Share by Manufacturers (2021-2026) Table 7. Global 10% Dextrose Injection Sales by Manufacturers (K L) & (2021-2026) Table 8. Global 10% Dextrose Injection Sales Market Share by Manufacturers Table 9. Global 10% Dextrose Injection Average Sales Price (US$/L) of Manufacturers (2021-2026) Table 10. Global 10% Dextrose Injection Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global 10% Dextrose Injection Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global 10% Dextrose Injection Manufacturers, Product Type & Application Table 13. Global 10% Dextrose Injection Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global 10% Dextrose Injection by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of 1000 mL Table 17. Major Manufacturers of 250 mL Table 18. Major Manufacturers of 500 mL Table 19. Global 10% Dextrose Injection Sales by Type 2021 VS 2025 VS 2032 (K L) Table 20. Global 10% Dextrose Injection Sales by Type (2021-2026) & (K L) Table 21. Global 10% Dextrose Injection Sales by Type (2027-2032) & (K L) Table 22. Global 10% Dextrose Injection Sales Market Share by Type (2021-2026) Table 23. Global 10% Dextrose Injection Sales Market Share by Type (2027-2032) Table 24. Global 10% Dextrose Injection Revenue by Type 2021 VS 2025 VS 2032 (K L) Table 25. Global 10% Dextrose Injection Revenue by Type (2021-2026) & (K L) Table 26. Global 10% Dextrose Injection Revenue by Type (2027-2032) & (K L) Table 27. Global 10% Dextrose Injection Revenue Market Share by Type (2021-2026) Table 28. Global 10% Dextrose Injection Revenue Market Share by Type (2027-2032) Table 29. Major Manufacturers of Trophotherapy Table 30. Major Manufacturers of Sports Table 31. Major Manufacturers of First-Aid Treatment Table 32. Major Manufacturers of Others Table 33. Global 10% Dextrose Injection Sales by Application 2021 VS 2025 VS 2032 (K L) Table 34. Global 10% Dextrose Injection Sales by Application (2021-2026) & (K L) Table 35. Global 10% Dextrose Injection Sales by Application (2027-2032) & (K L) Table 36. Global 10% Dextrose Injection Sales Market Share by Application (2021-2026) Table 37. Global 10% Dextrose Injection Sales Market Share by Application (2027-2032) Table 38. Global 10% Dextrose Injection Revenue by Application 2021 VS 2025 VS 2032 (K L) Table 39. Global 10% Dextrose Injection Revenue by Application (2021-2026) & (K L) Table 40. Global 10% Dextrose Injection Revenue by Application (2027-2032) & (K L) Table 41. Global 10% Dextrose Injection Revenue Market Share by Application (2021-2026) Table 42. Global 10% Dextrose Injection Revenue Market Share by Application (2027-2032) Table 43. Global 10% Dextrose Injection Sales by Region: 2021 VS 2025 VS 2032 (K L) Table 44. Global 10% Dextrose Injection Sales by Region (2021-2026) & (K L) Table 45. Global 10% Dextrose Injection Sales Market Share by Region (2021-2026) Table 46. Global 10% Dextrose Injection Sales Forecasted by Region (2027-2032) & (K L) Table 47. Global 10% Dextrose Injection Sales Forecasted Market Share by Region (2027-2032) Table 48. North America 10% Dextrose Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K L) Table 49. North America 10% Dextrose Injection Sales by Country (2021-2026) & (K L) Table 50. North America 10% Dextrose Injection Sales by Country (2027-2032) & (K L) Table 51. Europe 10% Dextrose Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K L) Table 52. Europe 10% Dextrose Injection Sales by Country (2021-2026) & (K L) Table 53. Europe 10% Dextrose Injection Sales by Country (2027-2032) & (K L) Table 54. Asia Pacific 10% Dextrose Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K L) Table 55. Asia Pacific 10% Dextrose Injection Sales by Country (2021-2026) & (K L) Table 56. Asia Pacific 10% Dextrose Injection Sales by Country (2027-2032) & (K L) Table 57. South America, Middle East and Africa 10% Dextrose Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K L) Table 58. South America, Middle East and Africa 10% Dextrose Injection Sales by Country (2021-2026) & (K L) Table 59. South America, Middle East and Africa 10% Dextrose Injection Sales by Country (2027-2032) & (K L) Table 60. Global 10% Dextrose Injection Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 61. Global 10% Dextrose Injection Revenue by Region (2021-2026) & (US$ Million) Table 62. Global 10% Dextrose Injection Revenue by Region (2027-2032) & (US$ Million) Table 63. Global 10% Dextrose Injection Revenue Market Share by Region (2021-2026) Table 64. Global 10% Dextrose Injection Revenue Market Share by Region (2027-2032) Table 65. Pfizer Company Information Table 66. Pfizer Business Overview Table 67. Pfizer 10% Dextrose Injection Sales (K L), Price (US$/L), Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Pfizer 10% Dextrose Injection Product Portfolio Table 69. Pfizer Recent Development Table 70. Fresenius Kabi Company Information Table 71. Fresenius Kabi Business Overview Table 72. Fresenius Kabi 10% Dextrose Injection Sales (K L), Price (US$/L), Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Fresenius Kabi 10% Dextrose Injection Product Portfolio Table 74. Fresenius Kabi Recent Development Table 75. Baxter Company Information Table 76. Baxter Business Overview Table 77. Baxter 10% Dextrose Injection Sales (K L), Price (US$/L), Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Baxter 10% Dextrose Injection Product Portfolio Table 79. Baxter Recent Development Table 80. Schwitz Biotech Company Information Table 81. Schwitz Biotech Business Overview Table 82. Schwitz Biotech 10% Dextrose Injection Sales (K L), Price (US$/L), Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Schwitz Biotech 10% Dextrose Injection Product Portfolio Table 84. Schwitz Biotech Recent Development Table 85. Otsuka Pharmaceutical Company Information Table 86. Otsuka Pharmaceutical Business Overview Table 87. Otsuka Pharmaceutical 10% Dextrose Injection Sales (K L), Price (US$/L), Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Otsuka Pharmaceutical 10% Dextrose Injection Product Portfolio Table 89. Otsuka Pharmaceutical Recent Development Table 90. ICU Medical Company Information Table 91. ICU Medical Business Overview Table 92. ICU Medical 10% Dextrose Injection Sales (K L), Price (US$/L), Revenue (US$ Million) and Gross Margin (2021-2026) Table 93. ICU Medical 10% Dextrose Injection Product Portfolio Table 94. ICU Medical Recent Development Table 95. Drugfield Pharmaceuticals Limited Company Information Table 96. Drugfield Pharmaceuticals Limited Business Overview Table 97. Drugfield Pharmaceuticals Limited 10% Dextrose Injection Sales (K L), Price (US$/L), Revenue (US$ Million) and Gross Margin (2021-2026) Table 98. Drugfield Pharmaceuticals Limited 10% Dextrose Injection Product Portfolio Table 99. Drugfield Pharmaceuticals Limited Recent Development Table 100. B. Braun Medical Inc Company Information Table 101. B. Braun Medical Inc Business Overview Table 102. B. Braun Medical Inc 10% Dextrose Injection Sales (K L), Price (US$/L), Revenue (US$ Million) and Gross Margin (2021-2026) Table 103. B. Braun Medical Inc 10% Dextrose Injection Product Portfolio Table 104. B. Braun Medical Inc Recent Development Table 105. Alfa Laboratories Company Information Table 106. Alfa Laboratories Business Overview Table 107. Alfa Laboratories 10% Dextrose Injection Sales (K L), Price (US$/L), Revenue (US$ Million) and Gross Margin (2021-2026) Table 108. Alfa Laboratories 10% Dextrose Injection Product Portfolio Table 109. Alfa Laboratories Recent Development Table 110. Key Raw Materials Table 111. Raw Materials Key Suppliers Table 112. 10% Dextrose Injection Distributors List Table 113. 10% Dextrose Injection Customers List Table 114. Research Programs/Design for This Report Table 115. Authors List of This Report Table 116. Secondary Sources Table 117. Primary Sources List of Figures Figure 1. 10% Dextrose Injection Product Image Figure 2. Global 10% Dextrose Injection Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global 10% Dextrose Injection Market Size (2021-2032) & (US$ Million) Figure 4. Global 10% Dextrose Injection Sales (2021-2032) & (K L) Figure 5. Global 10% Dextrose Injection Average Price (US$/L) & (2021-2032) Figure 6. Global Top 5 and 10 10% Dextrose Injection Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. 1000 mL Image Figure 9. 250 mL Image Figure 10. 500 mL Image Figure 11. Global 10% Dextrose Injection Sales by Type (2021 VS 2025 VS 2032) & (K L) Figure 12. Global 10% Dextrose Injection Sales Market Share 2021 VS 2025 VS 2032 Figure 13. Global 10% Dextrose Injection Sales Market Share by Type (2021-2032) Figure 14. Global 10% Dextrose Injection Revenue by Type (2021 VS 2025 VS 2032) & (K L) Figure 15. Global 10% Dextrose Injection Revenue Market Share 2021 VS 2025 VS 2032 Figure 16. Global 10% Dextrose Injection Revenue Market Share by Type (2021-2032) Figure 17. Trophotherapy Image Figure 18. Sports Image Figure 19. First-Aid Treatment Image Figure 20. Others Image Figure 21. Global 10% Dextrose Injection Sales by Application (2021 VS 2025 VS 2032) & (K L) Figure 22. Global 10% Dextrose Injection Sales Market Share 2021 VS 2025 VS 2032 Figure 23. Global 10% Dextrose Injection Sales Market Share by Application (2021-2032) Figure 24. Global 10% Dextrose Injection Revenue by Application (2021 VS 2025 VS 2032) & (K L) Figure 25. Global 10% Dextrose Injection Revenue Market Share 2021 VS 2025 VS 2032 Figure 26. Global 10% Dextrose Injection Revenue Market Share by Application (2021-2032) Figure 27. North America 10% Dextrose Injection Sales and Growth Rate (2021-2032) & (K L) Figure 28. North America 10% Dextrose Injection Sales Market Share by Country (2021-2032) Figure 29. U.S. 10% Dextrose Injection Sales and Growth Rate (2021-2032) & (K L) Figure 30. Canada 10% Dextrose Injection Sales and Growth Rate (2021-2032) & (K L) Figure 31. Mexico 10% Dextrose Injection Sales and Growth Rate (2021-2032) & (K L) Figure 32. Europe 10% Dextrose Injection Sales and Growth Rate (2021-2032) & (K L) Figure 33. Europe 10% Dextrose Injection Sales Market Share by Country (2021-2032) Figure 34. Germany 10% Dextrose Injection Sales and Growth Rate (2021-2032) & (K L) Figure 35. France 10% Dextrose Injection Sales and Growth Rate (2021-2032) & (K L) Figure 36. U.K. 10% Dextrose Injection Sales and Growth Rate (2021-2032) & (K L) Figure 37. Italy 10% Dextrose Injection Sales and Growth Rate (2021-2032) & (K L) Figure 38. Netherlands 10% Dextrose Injection Sales and Growth Rate (2021-2032) & (K L) Figure 39. Asia Pacific 10% Dextrose Injection Sales and Growth Rate (2021-2032) & (K L) Figure 40. Asia Pacific 10% Dextrose Injection Sales Market Share by Country (2021-2032) Figure 41. China 10% Dextrose Injection Sales and Growth Rate (2021-2032) & (K L) Figure 42. Japan 10% Dextrose Injection Sales and Growth Rate (2021-2032) & (K L) Figure 43. South Korea 10% Dextrose Injection Sales and Growth Rate (2021-2032) & (K L) Figure 44. Southeast Asia 10% Dextrose Injection Sales and Growth Rate (2021-2032) & (K L) Figure 45. India 10% Dextrose Injection Sales and Growth Rate (2021-2032) & (K L) Figure 46. Australia 10% Dextrose Injection Sales and Growth Rate (2021-2032) & (K L) Figure 47. South America, Middle East and Africa 10% Dextrose Injection Sales and Growth Rate (2021-2032) & (K L) Figure 48. South America, Middle East and Africa 10% Dextrose Injection Sales Market Share by Country (2021-2032) Figure 49. Brazil 10% Dextrose Injection Sales and Growth Rate (2021-2032) & (K L) Figure 50. South Africa 10% Dextrose Injection Sales and Growth Rate (2021-2032) & (K L) Figure 51. Saudi Arabia 10% Dextrose Injection Sales and Growth Rate (2021-2032) & (K L) Figure 52. Turkey 10% Dextrose Injection Sales and Growth Rate (2021-2032) & (K L) Figure 53. Argentina 10% Dextrose Injection Sales and Growth Rate (2021-2032) & (K L) Figure 54. UAE 10% Dextrose Injection Sales and Growth Rate (2021-2032) & (K L) Figure 55. Egypt 10% Dextrose Injection Sales and Growth Rate (2021-2032) & (K L) Figure 56. Chile 10% Dextrose Injection Sales and Growth Rate (2021-2032) & (K L) Figure 57. Global 10% Dextrose Injection Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Global 10% Dextrose Injection Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 59. North America 10% Dextrose Injection Revenue (2021-2032) & (US$ Million) Figure 60. North America 10% Dextrose Injection Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Europe 10% Dextrose Injection Revenue (2021-2032) & (US$ Million) Figure 62. Europe 10% Dextrose Injection Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. Asia-Pacific 10% Dextrose Injection Revenue (2021-2032) & (US$ Million) Figure 64. Asia-Pacific 10% Dextrose Injection Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. South America, Middle East and Africa 10% Dextrose Injection Revenue (2021-2032) & (US$ Million) Figure 66. South America, Middle East and Africa 10% Dextrose Injection Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. 10% Dextrose Injection Value Chain Figure 68. Manufacturing Cost Structure Figure 69. 10% Dextrose Injection Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • 1000 mL
  • 250 mL
  • 500 mL
Applications
  • Trophotherapy
  • Sports
  • First-Aid Treatment
  • Others
Companies covered
  • Pfizer
  • Fresenius Kabi
  • Baxter
  • Schwitz Biotech
  • Otsuka Pharmaceutical
  • ICU Medical
  • Drugfield Pharmaceuticals Limited
  • B. Braun Medical Inc
  • Alfa Laboratories

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global 10% Dextrose Injection Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global 10% Dextrose Injection Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global 10% Dextrose Injection Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global 10% Dextrose Injection Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global 10% Dextrose Injection Market Dynamics
  1. 2.1 10% Dextrose Injection Industry Trends
  2. 2.2 10% Dextrose Injection Industry Drivers
  3. 2.3 10% Dextrose Injection Industry Opportunities and Challenges
  4. 2.4 10% Dextrose Injection Industry Restraints
3 10% Dextrose Injection Market by Manufacturers
  1. 3.1 Global 10% Dextrose Injection Revenue by Manufacturers (2021-2026)
  2. 3.2 Global 10% Dextrose Injection Sales by Manufacturers (2021-2026)
  3. 3.3 Global 10% Dextrose Injection Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global 10% Dextrose Injection Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global 10% Dextrose Injection Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global 10% Dextrose Injection Manufacturers, Product Type & Application
  7. 3.7 Global 10% Dextrose Injection Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global 10% Dextrose Injection Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 10% Dextrose Injection Players Market Share by Revenue in 2025
  11. 3.8.3 2025 10% Dextrose Injection Tier 1, Tier 2, and Tier 3
4 10% Dextrose Injection Market by Type
  1. 4.1 10% Dextrose Injection Type Introduction
  2. 4.1.1 1000 mL
  3. 4.1.2 250 mL
  4. 4.1.3 500 mL
  5. 4.2 Global 10% Dextrose Injection Sales by Type
  6. 4.2.1 Global 10% Dextrose Injection Sales by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global 10% Dextrose Injection Sales by Type (2021-2032)
  8. 4.2.3 Global 10% Dextrose Injection Sales Market Share by Type (2021-2032)
  9. 4.3 Global 10% Dextrose Injection Revenue by Type
  10. 4.3.1 Global 10% Dextrose Injection Revenue by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global 10% Dextrose Injection Revenue by Type (2021-2032)
  12. 4.3.3 Global 10% Dextrose Injection Revenue Market Share by Type (2021-2032)
5 10% Dextrose Injection Market by Application
  1. 5.1 10% Dextrose Injection Application Introduction
  2. 5.1.1 Trophotherapy
  3. 5.1.2 Sports
  4. 5.1.3 First-Aid Treatment
  5. 5.1.4 Others
  6. 5.2 Global 10% Dextrose Injection Sales by Application
  7. 5.2.1 Global 10% Dextrose Injection Sales by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global 10% Dextrose Injection Sales by Application (2021-2032)
  9. 5.2.3 Global 10% Dextrose Injection Sales Market Share by Application (2021-2032)
  10. 5.3 Global 10% Dextrose Injection Revenue by Application
  11. 5.3.1 Global 10% Dextrose Injection Revenue by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global 10% Dextrose Injection Revenue by Application (2021-2032)
  13. 5.3.3 Global 10% Dextrose Injection Revenue Market Share by Application (2021-2032)
6 Global 10% Dextrose Injection Sales by Region
  1. 6.1 Global 10% Dextrose Injection Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global 10% Dextrose Injection Sales by Region (2021-2032)
  3. 6.2.1 Global 10% Dextrose Injection Sales by Region (2021-2026)
  4. 6.2.2 Global 10% Dextrose Injection Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America 10% Dextrose Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America 10% Dextrose Injection Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe 10% Dextrose Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe 10% Dextrose Injection Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific 10% Dextrose Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific 10% Dextrose Injection Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa 10% Dextrose Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa 10% Dextrose Injection Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global 10% Dextrose Injection Revenue by Region
  1. 7.1 Global 10% Dextrose Injection Revenue by Region
  2. 7.1.1 Global 10% Dextrose Injection Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global 10% Dextrose Injection Revenue by Region (2021-2026)
  4. 7.1.3 Global 10% Dextrose Injection Revenue by Region (2027-2032)
  5. 7.1.4 Global 10% Dextrose Injection Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America 10% Dextrose Injection Revenue (2021-2032)
  8. 7.2.2 North America 10% Dextrose Injection Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe 10% Dextrose Injection Revenue (2021-2032)
  11. 7.3.2 Europe 10% Dextrose Injection Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific 10% Dextrose Injection Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific 10% Dextrose Injection Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa 10% Dextrose Injection Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa 10% Dextrose Injection Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Pfizer
  2. 8.1.1 Pfizer Company Information
  3. 8.1.2 Pfizer Business Overview
  4. 8.1.3 Pfizer 10% Dextrose Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Pfizer 10% Dextrose Injection Product Portfolio
  6. 8.1.5 Pfizer Recent Developments
  7. 8.2 Fresenius Kabi
  8. 8.2.1 Fresenius Kabi Company Information
  9. 8.2.2 Fresenius Kabi Business Overview
  10. 8.2.3 Fresenius Kabi 10% Dextrose Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Fresenius Kabi 10% Dextrose Injection Product Portfolio
  12. 8.2.5 Fresenius Kabi Recent Developments
  13. 8.3 Baxter
  14. 8.3.1 Baxter Company Information
  15. 8.3.2 Baxter Business Overview
  16. 8.3.3 Baxter 10% Dextrose Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Baxter 10% Dextrose Injection Product Portfolio
  18. 8.3.5 Baxter Recent Developments
  19. 8.4 Schwitz Biotech
  20. 8.4.1 Schwitz Biotech Company Information
  21. 8.4.2 Schwitz Biotech Business Overview
  22. 8.4.3 Schwitz Biotech 10% Dextrose Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Schwitz Biotech 10% Dextrose Injection Product Portfolio
  24. 8.4.5 Schwitz Biotech Recent Developments
  25. 8.5 Otsuka Pharmaceutical
  26. 8.5.1 Otsuka Pharmaceutical Company Information
  27. 8.5.2 Otsuka Pharmaceutical Business Overview
  28. 8.5.3 Otsuka Pharmaceutical 10% Dextrose Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Otsuka Pharmaceutical 10% Dextrose Injection Product Portfolio
  30. 8.5.5 Otsuka Pharmaceutical Recent Developments
  31. 8.6 ICU Medical
  32. 8.6.1 ICU Medical Company Information
  33. 8.6.2 ICU Medical Business Overview
  34. 8.6.3 ICU Medical 10% Dextrose Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 ICU Medical 10% Dextrose Injection Product Portfolio
  36. 8.6.5 ICU Medical Recent Developments
  37. 8.7 Drugfield Pharmaceuticals Limited
  38. 8.7.1 Drugfield Pharmaceuticals Limited Company Information
  39. 8.7.2 Drugfield Pharmaceuticals Limited Business Overview
  40. 8.7.3 Drugfield Pharmaceuticals Limited 10% Dextrose Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Drugfield Pharmaceuticals Limited 10% Dextrose Injection Product Portfolio
  42. 8.7.5 Drugfield Pharmaceuticals Limited Recent Developments
  43. 8.8 B. Braun Medical Inc
  44. 8.8.1 B. Braun Medical Inc Company Information
  45. 8.8.2 B. Braun Medical Inc Business Overview
  46. 8.8.3 B. Braun Medical Inc 10% Dextrose Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 B. Braun Medical Inc 10% Dextrose Injection Product Portfolio
  48. 8.8.5 B. Braun Medical Inc Recent Developments
  49. 8.9 Alfa Laboratories
  50. 8.9.1 Alfa Laboratories Company Information
  51. 8.9.2 Alfa Laboratories Business Overview
  52. 8.9.3 Alfa Laboratories 10% Dextrose Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Alfa Laboratories 10% Dextrose Injection Product Portfolio
  54. 8.9.5 Alfa Laboratories Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 10% Dextrose Injection Value Chain Analysis
  2. 9.1.1 10% Dextrose Injection Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 10% Dextrose Injection Production Mode & Process
  6. 9.2 10% Dextrose Injection Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 10% Dextrose Injection Distributors
  9. 9.2.3 10% Dextrose Injection Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst